BioMarin to Host Second Quarter 2025 Financial Results Conference Call and Webcast on Monday, August 4, 2025, at 4:30pm ET

Rhea-AI Summary

BioMarin Pharmaceutical (NASDAQ: BMRN) has scheduled its second quarter 2025 financial results conference call and webcast for Monday, August 4, 2025, at 4:30 p.m. ET. The company's President and CEO, Alexander Hardy, will lead the discussion of Q2 2025 financial performance and provide business updates.

Investors and interested parties can access the live audio webcast through BioMarin's investor relations website. A replay will be available for one week after the call. The company has provided both domestic and international dial-in numbers for telephone access to the conference call.

News Market Reaction

+4.67%

1 alert

+4.67% News Effect

On the day this news was published, BMRN gained 4.67%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

SAN RAFAEL, Calif., July 22, 2025 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Alexander Hardy, President and Chief Executive Officer of BioMarin, will host a conference call and webcast on Monday, August 4, 2025, at 4:30 p.m. ET to discuss second quarter 2025 financial results and provide a general business update.

Dial-in Number 
U.S. / Canada Dial-in Number: 800-715-9871
International Dial-in Number: 646-307-1963
Conference Call ID: 6336054 

U.S. / Canada Replay Dial-in Number: 800-770-2030
International Replay Dial-in Number: 609-800-9909
Playback ID: 6336054

Interested parties may access a live audio webcast of the conference call via the investor section of the BioMarin website, https://investors.biomarin.com/. A replay of the call will be archived on the site for one week following the call.

About BioMarin
BioMarin is a global biotechnology company dedicated to translating the promise of genetic discovery into medicines that make a profound impact on the life of each patient. The San Rafael, California-based company, founded in 1997, has a proven track record of innovation with eight commercial therapies and a strong clinical and preclinical pipeline. Using a distinctive approach to drug discovery and development, BioMarin pursues treatments that offer new possibilities for patients and families around the world navigating rare or difficult-to-treat genetic conditions. To learn more, please visit www.biomarin.com. 

Contacts:
Investors	Media
Traci McCarty	Marni Kottle
BioMarin Pharmaceutical Inc.	BioMarin Pharmaceutical Inc.
(415) 455-7558	(650) 374-2803

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/biomarin-to-host-second-quarter-2025-financial-results-conference-call-and-webcast-on-monday-august-4-2025-at-430pm-et-302510004.html

SOURCE BioMarin Pharmaceutical Inc.

FAQ

When is BioMarin (BMRN) reporting Q2 2025 earnings?

BioMarin will report its Q2 2025 earnings on Monday, August 4, 2025, at 4:30 p.m. ET.

How can I listen to BioMarin's Q2 2025 earnings call?

You can access the live audio webcast through BioMarin's investor website or dial in using U.S./Canada number (800-715-9871) or International number (646-307-1963) with Conference ID: 6336054.

Who will host BioMarin's Q2 2025 earnings call?

Alexander Hardy, BioMarin's President and Chief Executive Officer, will host the conference call.

How long will BioMarin's Q2 2025 earnings call replay be available?

The replay will be available on BioMarin's investor website for one week following the call.